BVCF

About The Fund

BVCF, known as BioVeda China Fund, is a venture capital firm that was established in 2005 with a sharp focus on the life sciences and healthcare sectors, predominantly within the realms of China and the United States. They concentrate their investment activities in healthcare services, innovative biological research, in-vitro diagnostics including molecular diagnostics, high-value medical equipment and consumables, alongside medical big data and mobile medicine. Their investment strategy is firmly placed in leveraging opportunities that will position China as a creator of global life science giants over the forthcoming decades. They maintain a forward-looking strategy that gains its prowess from a deep understanding of technological advances, policy shifts, and market opportunities. This strategy is executed by a seasoned investment team brought together by BVCF. The goal of BVCF is not only to generate returns but also to contribute to the health and wealth of the world by promoting the growth and innovation of global Chinese Life Sciences companies. This vision has allowed them to attract a variety of global institutional financial and strategic investors to their fund. By delving into life science advancements, BVCF aims to capitalize on the industry's growth and bring cutting-edge solutions to a global market, especially understanding the potential held within the intersection of life sciences and technology-driven platforms such as big data and mobile health.